Late-onset hypogonadism: The advantages of treatment with human chorionic gonadotropin rather than testosterone

Aging Male

Volumn 19, Issue 1, 2016, Pages 34-39

  La Vignera, Sandro ^a   Condorelli, Rosita Angela ^a   Cimino, Laura ^a   Russo, Giorgio Ivan ^b   Morgia, Giuseppe ^b   Calogero, Aldo E ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Human chorionic gonadotropin; late onset hypogonadism; testosterone

Indexed keywords

25 HYDROXYVITAMIN D; CHORIONIC GONADOTROPIN; ESTROGEN; LUTEINIZING HORMONE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE; VITAMIN D;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CLINICAL ARTICLE; DRUG SAFETY; ESTROGEN BLOOD LEVEL; HEMATOCRIT; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; LEYDIG CELL; MALE; MALE INFERTILITY; METABOLIC PARAMETERS; PRIORITY JOURNAL; PROSTATE SIZE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEMEN ANALYSIS; SIDE EFFECT; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ADVERSE EFFECTS; BLOOD; COMPLICATION; CONTROLLED STUDY; CUTANEOUS DRUG ADMINISTRATION; DRUG ADMINISTRATION; DRUG EFFECTS; INTRAMUSCULAR DRUG ADMINISTRATION; MIDDLE AGED; PROCEDURES; PROSTATE; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, CUTANEOUS; CHORIONIC GONADOTROPIN; DRUG ADMINISTRATION SCHEDULE; HEMATOCRIT; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; SURVEYS AND QUESTIONNAIRES; TESTOSTERONE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84944931131     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.3109/13685538.2015.1092021     Document Type: Article

References (29)

1. Lunenfeld B, Mskhalaya G, Zitzmann M, et al. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male 2015; 18: 5-15
2. Tajar A, Huhtaniemi IT, ONeill TW, et al. Characteristics of androgen deficiency in late-onset hypogonadism: Results from the European Male Aging Study (EMAS). J Clin Endocrinol Metab 2012; 97: 1508-16
3. Buvat J, Maggi M, Guay A, Torres LO. Testosterone deficiency in men: Systematic review and standard operating procedures for diagnosis and treatment. J Sex Med 2013; 10: 245-84
4. Huhtaniemi I. Late-onset hypogonadism: Current concepts and controversies of pathogenesis, diagnosis and treatment. Asian J Androl 2014; 16: 192-202
5. La Vignera S, Condorelli R, Vicari E, et al. Original immunophenotype of blood endothelial progenitor cells and microparticles in patients with isolated arterial erectile dysfunction and late onset hypogonadism: Effects of androgen replacement therapy. Aging Male 2011; 14: 183-9
6. Almehmadi Y1, Yassin DJ, Yassin AA. Erectile dysfunction is a prognostic indicator of comorbidities in men with late onset hypogonadism. Aging Male 2015; 1: 1-9. DOI: 10.3109/13685538.2015.1046044
7. Leung KM, Alrabeeah K, Carrier S. Update on testosterone replacement therapy in hypogonadal men. Curr Urol Rep 2015; 16: 523
8. Katib AA, Al-Hawsawi K, Motair W, Bawa AM. Secondary infertility and the aging male, overview. Cent Eur J Urol 2014; 67: 184-8
9. McCullough A. Alternatives to testosterone replacement: Testosterone restoration. Asian J Androl 2015; 17: 201-5
10. Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 2008; 159: 507-14
11. World Health Organization. WHO Laboratory Manual for the Examination and processing of human semen. 5th ed. Cambridge: Cambridge University Press; 2010
12. Barry MJ, Fowler FJ Jr, OLeary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549-57
13. Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319-26
14. Heinemann LA, Saad F, Zimmermann T, et al. The Aging Males Symptoms (AMS) scale: Update and compilation of international versions. Health Qual Life Outcomes 2003; 1: 15
15. Bilgi M, Güllü H, Kozanoʇlu ̄, et al. Evaluation of blood rheology in patients with coronary slow flow or non-obstructive coronary artery disease. Clin Hemorheol Microcirc 2013; 53: 317-26
16. Kaufman JM, Giri M, Deslypere JM, et al. Influence of age on the responsiveness of the gonadotrophs to luteinizing hormone-releasing hormone in males. J Clin Endocrinol Metab 1991; 72: 1255-60
17. Turek PJ, Williams RH, Gilbaugh JH III, Lipshultz LI. The reversibility of anabolic steroid-induced azoospermia. J Urol 1995; 153: 1628-30
18. Liu PY, Wishart SM, Handelsman DJ. A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency. J Clin Endocrinol Metab 2002; 87: 3125-35
19. Depenbusch M, von Eckardstein S, Simoni M, Nieschlag E. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone. Eur J Endocrinol 2002; 147: 617-24
20. Coviello AD1, Matsumoto AM, Bremner WJ, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab 2005; 90: 2595-602
21. Hsieh TC, Pastuszak AW, Hwang K, Lipshultz LI. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol 2013; 189: 647-50
22. Foresta C, Strapazzon G, De Toni L, et al. Bone mineral density and testicular failure: Evidence for a role of vitamin D 25-hydroxylase in human testis. J Clin Endocrinol Metab 2011; 96: E646-52
23. Hammoud AO, Meikle AW, Peterson CM, et al. Association of 25-hydroxy-vitamin D levels with semen and hormonal parameters. Asian J Androl 2012; 14: 855-9
24. Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: A systematic review. Eur J Endocrinol 2012; 166: 765-78
25. Ramlau-Hansen CH, Moeller UK, Bonde JP, et al. Are serum levels of vitamin D associated with semen quality? Results from a cross-sectional study in young healthy men. Fertil Steril 2011; 95: 1000-4
26. Correia S, Alves MR, Cavaco JE, et al. Estrogenic regulation of testicular expression of stem cell factor and c-kit: Implications in germ cell survival and male fertility. Fertil Steril 2014; 102: 299-306
27. Mancini A, Raimondo S, Persano M, et al. Estrogens as antioxidant modulators in human fertility. Int J Endocrinol 2013; 2013: 607939
28. Finkelstein JS, Yu EW, Burnett-Bowie SA. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med 2013; 369: 1011-22
29. Bryant C, Moore J, Curry TE Jr. Determination of serum estradiol levels by radiometric and chemiluminescent techniques. Methods Mol Biol 2009; 590: 21-32